SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999; 281: 15911597.
  • 2
    Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 1996; 276: 615619.
  • 3
    D'Amico AV, Whittington R, Malkowicz SB, et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol. 1995; 154: 131138.
  • 4
    Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol. 2001; 165: 119125.
  • 5
    Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999; 17: 14991507.
  • 6
    BeahrsO, HensonD, HutterR, et al., editors. AJCC cancer staging manual, 4th ed. Philadelphia: Lippincott-Raven, 1992.
  • 7
    Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998; 90: 766771.
  • 8
    Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am. 1997; 24: 395406.
  • 9
    FlemingID, CooperJS, HensonDE, et al., editors. AJCC cancer staging manual 5th ed. Philadelphia: Lippincott-Raven, 1998.
  • 10
    GreeneFL, PageDL, FlemingID, et al., editors AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002.
  • 11
    May F, Hartung R, Breul J. The ability of the American Joint Committee on Cancer staging system to predict progression-free survival after radical prostatectomy. BJU Int. 2001; 88: 702707.
  • 12
    Yossepowitch O, Engelstein D, Konichezky M, Sella A, Livne PM, Baniel J. Bladder neck involvement at radical prostatectomy: positive margins or advanced T4 disease? Urology. 2000; 56: 448452.
  • 13
    Conrad S, Graefen M, Pichlmeier U, et al. Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol. 2002; 167( 2 Pt 1): 521525.
  • 14
    McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988; 12: 897906.
  • 15
    Gleason DF. Histologic grading and clinical staging of prostate carcinoma. In: TannenbaumM, editor. Urologic pathology: the prostate. Philadelphia: Lea and Feibiger, 1977: 171197.
  • 16
    Begg CB, Cramer LD, Venkatraman ES, Rosai J. Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. Stat Med. 2000; 19: 19972014.
  • 17
    Graefen M, Ohori M, Karakiewicz PI, et al. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J Urol. 2004; 171: 200203.
  • 18
    Cagiannos I, Graefen M, Karakiewicz PI, et al. Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement? J Clin Oncol. 2002; 20: 20252030.
  • 19
    Noldus J, Graefen M, Haese A, Henke RP, Hammerer P, Huland H. Stage migration in clinically localized prostate cancer. Eur Urol. 2000; 38: 7478.
  • 20
    Dillioglugil O, Leibman BD, Kattan MW, Seale-Hawkins C, Wheeler TM, Scardino PT. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology. 1997; 50: 9399.
  • 21
    Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000; 164: 101105.